Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 3.782.822.952.812.26

What is the latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of BAFNA PHARMACEUTICALS is 3.78 based on Mar2024 Standalone results.
Year Working Capital/Sales
Mar20243.78
Mar20232.82
Mar20222.95
Mar20212.81
Mar20202.26

How is Working Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 3.78
34.04
Mar2023 2.82
-4.41
Mar2022 2.95
4.98
Mar2021 2.81
24.34
Mar2020 2.26 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹202.6 Cr -4.5% -5.4% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr -4.3% -3% -0.7% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -3.3% -7.4% 34.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 1.4% 10.1% 17.9% Stock Analytics
CIPLA ₹121,260.0 Cr -4.4% -0.5% 0.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -5.2% -5.7% -5.9% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-4.5%

-5.4%

0.8%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses